Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel, small molecule therapies for patients in need of new treatments across many complicated diseases. These patients simply cannot wait on traditional discovery methods. That’s why at Aria, we have redefined the drug discovery approach, increasing success rates by mitigating risks throughout the drug development process. We’ve shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases.
|